Ascentage Pharma vs Volastra Therapeutics

Volastra Therapeutics

Clinical stage biotech developing a powerful new class of cancer therapies exploiting chromosomal instability

41 employees · est. 2019 · New York, United States

Ascentage Pharma is the older company (2009 vs 2019); Ascentage Pharma is the larger of the two.

Side-by-Side Comparison

Metric	Ascentage Pharma	Volastra Therapeutics
Founded
Founded	2009 older	2019
Headquarters
Headquarters	China	New York, United States
Employees
Employees	134 larger	41
Industry
Industry	Biopharma, Biotechnology, Pharmaceutical	Biotechnology, Life Sciences
Funding Stage
Funding Stage	Post-IPO Equity	Venture round
Total Funding
Total Funding	$740.50M	$119.00M
Funding Rounds
Funding Rounds	4	4
Taxonomy
Taxonomy	Clinical-stageTherapiesCancerCHBSenesce DiseasesApoptosis Inhibitors +8	BiotechCancer TherapiesChromosomal InstabilityDrug DiscoveryTherapeuticsSynthetic Lethal Pipeline +8
Website
Website	ascentagepharma.com	volastratx.com

About Ascentage Pharma

Ascentage Pharma is a global, clinical-stage biotechnology company established in 2009 and headquartered in China. The company focuses on developing innovative therapies for cancers, CHB, and senesce diseases. On October 28, 2019, Ascentage Pharma was listed on the Main Board of the Stock Exchange o...

View Full Profile

About Volastra Therapeutics

Volastra Therapeutics, a New York-based biotech firm, is at the forefront of developing innovative cancer therapies targeting chromosomal instability (CIN). Founded in 2019 by Lewis Cantley, Ph.D., Olivier Elemento, Ph.D., and Samuel Bakhoum, M.D., Ph.D., the company focuses on leveraging CIN, recog...

View Full Profile Alternatives

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Ascentage Pharma and Volastra Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Ascentage Pharma or Volastra Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Frequently Asked Questions

Ascentage Pharma was founded in 2009, based in China, with 134 employees. Ascentage Pharma is a global, clinical-stage biotechnology company established in 2009 and headquartered in China. The company focuses on developing innovative therapies for cancers, CHB, and senesce. Volastra Therapeutics was founded in 2019, based in New York, United States, with 41 employees. Volastra Therapeutics, a New York-based biotech firm, is at the forefront of developing innovative cancer therapies targeting chromosomal instability (CIN). Founded in 2019 by Lewis Cantley, Ph.D., Ol.

Ascentage Pharma has raised $740.50M and Volastra Therapeutics $119.00M. Latest stage: Ascentage Pharma Post-IPO Equity, Volastra Therapeutics Venture round.

Both work in Biotechnology and list clinical trials among their focus areas.

Compare Ascentage Pharma with someone else

Start typing a company name or domain.

Related Comparisons

Ascentage Pharma vs GLG Pharma Volastra Therapeutics Alternatives All Companies All Signals

Compiled from the BounceWatch company index. We last looked at Ascentage Pharma on 12 Sep 2024, and Volastra Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.